What Actually Happens to a Follicle During Shedding

Every strand of hair that appears in a brush or shower drain did not break — it was released. The follicle that produced it completed a programmed sequence of activity and rest, ending with a deliberate detachment event. This process, called the hair growth cycle, is a normal feature of scalp biology and not an indicator of damage on its own.

Understanding what a follicle does during shedding requires separating the cycle into its distinct phases. The shedding stage is not the same as the growth stage, and the two can overlap within the same follicle across time. This piece covers the cellular and structural events that occur specifically when a follicle winds down production and releases the hair shaft it has grown.

The Four Phases of Hair Follicle Growth and What Each One Does

The hair growth cycle consists of four recognized phases: anagen, catagen, telogen, and exogen. Each phase represents a distinct biological state of the follicle, and the transition between them is driven by molecular signaling rather than mechanical wear.

During anagen, the active growth phase, dermal papilla cells at the base of the follicle communicate with matrix keratinocytes — the cells responsible for producing the hair shaft. These keratinocytes divide rapidly, differentiate, and become the structural proteins that form the cortex, medulla, and cuticle of a growing strand. Anagen can last anywhere from two to seven years depending on the individual and the body region, which is why scalp hair grows much longer than eyebrow hair before it sheds.

The transition into catagen marks the end of active production. Programmed cell death, or apoptosis, sweeps through the lower follicle. The dermal papilla condenses and moves upward toward the skin surface as the follicle itself shortens. The hair shaft stops elongating and its base hardens into a structure called the club hair — a rounded, unpigmented root that anchors the strand loosely in place. Catagen lasts approximately two to three weeks.

In telogen, the follicle enters a true resting state. The club hair sits near the surface while the dermal papilla waits below it in a quiescent cluster. No new shaft is being built. Roughly 10–15 percent of scalp follicles are in telogen at any given moment in a healthy adult, which is why a baseline of daily shedding — typically cited in the range of 50 to 100 strands — is considered normal. Telogen can last two to four months.

The final phase, exogen, is the active shedding event itself. Once recognized as a distinct phase, exogen involves enzymatic loosening of the inner root sheath that holds the club hair in the follicular canal. Proteases — enzymes that break down structural proteins — degrade the attachment between the club hair and the surrounding tissue, allowing the strand to release with minimal force. The follicle then re-enters anagen, and the cycle begins again. This is what makes the structural integrity of the hair shaft during its growth phase particularly relevant — the shaft produced in anagen is the one that will eventually be released in exogen.

The Cellular and Molecular Components Driving Each Transition

Dermal papilla cells are the primary signaling hub of the follicle. They release growth factors — including members of the Wnt and Sonic Hedgehog signaling pathways — that instruct matrix keratinocytes to proliferate during anagen. When these signals diminish, the follicle begins its exit from active growth.

Matrix keratinocytes are the production workforce. They divide at one of the highest rates of any cell in the human body during anagen, then undergo controlled apoptosis during catagen. Their differentiation into cortical cells, cuticle cells, and medullary cells determines the cross-sectional architecture of the shaft — a structure that, once keratinized, is chemically inert and no longer biologically active. This is why what happens to the shaft after it emerges is entirely a surface chemistry story rather than a biological one.

The inner root sheath (IRS) is a tubular scaffold that surrounds the growing shaft inside the follicle. It is composed of its own keratins and hardens as it moves upward. During exogen, proteolytic enzymes degrade the IRS proteins at the point of attachment, facilitating release of the club hair without tearing the follicle wall.

Apoptosis-regulating proteins, particularly members of the Bcl-2 family, govern which cells survive catagen and which are eliminated. The balance between pro-apoptotic and anti-apoptotic signals determines the speed and completeness of the follicle's regression. Disruptions to this balance — whether from nutritional deficits, hormonal shifts, or physiological stress — can alter the proportion of follicles entering telogen simultaneously, which is the mechanism behind the diffuse shedding event known as telogen effluvium.

Androgens, particularly dihydrotestosterone (DHT), interact with androgen receptors in dermal papilla cells. In follicles that are genetically sensitive to this interaction, repeated androgen signaling progressively shortens the anagen phase across successive cycles — a process called follicular miniaturization. The follicle does not disappear immediately; it produces progressively finer, shorter shafts over many cycles before activity diminishes substantially.

Where the Shedding Cycle Breaks Down or Produces Unexpected Results

The most common misunderstanding about shedding is that it is proportional to how much the hair is handled or what products are applied to the shaft. The shaft itself is dead tissue — it contains no living cells after it exits the follicle opening. Mechanical stress can break a shaft mid-length, but it does not accelerate the biological release of a club hair from a follicle. Breakage and shedding are structurally different events with different origins.

Telogen effluvium illustrates where the cycle can be disrupted at a systemic level. A significant physiological stressor — fever, surgery, rapid caloric restriction, childbirth, or severe psychological stress — can push an abnormally large proportion of follicles into telogen simultaneously. The shedding that results typically appears two to four months later, when those follicles reach exogen. Because the delay between trigger and visible shedding is so long, the connection between cause and effect is frequently missed.

Androgenic alopecia represents a different failure mode: the cycle itself is intact, but the anagen phase shortens with each successive cycle due to androgen sensitivity in the dermal papilla. The follicle continues to cycle, but the shafts it produces become progressively finer and shorter — a process that unfolds over years or decades and is distinct from the temporary disruption of telogen effluvium. Diagnosing the difference between these two patterns requires clinical evaluation, not self-assessment.

Scalp inflammation — from conditions such as seborrheic dermatitis or folliculitis — can also interfere with normal cycling by disrupting the follicular microenvironment. Chronic inflammation around the follicle opening can impair the signaling environment that the dermal papilla depends on, though the precise molecular pathways involved are still an active area of research.

What Follicle Biology Reveals — and What It Does Not

A trichogram — a microscopic examination of plucked hairs — can identify whether shed hairs have a club root (indicating normal telogen release) or a tapered, unpigmented tip (indicating breakage). Trichoscopy, a dermoscopic examination of the scalp surface, can reveal follicular unit density, the presence of miniaturized follicles, and signs of perifollicular inflammation. These tools give a clinician information about what phase follicles are in and whether miniaturization is occurring, but they do not identify the cause of any disruption on their own.

Blood panels measuring ferritin, thyroid hormones, and sex hormone levels are frequently ordered alongside scalp assessments because systemic conditions are common drivers of cycle disruption. A follicle-level observation cannot distinguish a nutritional cause from a hormonal one without systemic data.

Product labels and cosmetic claims do not address follicle biology in any regulated, evidence-based way. The U.S. Food and Drug Administration classifies topical cosmetic products — shampoos, conditioners, scalp serums — as cosmetics unless they contain an active drug ingredient. A cosmetic product is legally defined as one that does not alter the structure or function of the body. Accordingly, no cosmetic label can accurately claim to restart anagen, extend the growth phase, or alter the cellular signaling within a follicle. Claims that imply otherwise are outside the cosmetic regulatory category and would require drug classification. This is a meaningful distinction when evaluating any product marketed around scalp or hair health — the shaft and the follicle are biologically separate systems, and what reaches one does not necessarily reach the other.

The follicle's shedding cycle is a tightly regulated biological program, not a passive response to external conditions — the club hair released in exogen was committed to that fate weeks before it became visible in a brush.

Note: This explains how hair products and treatments work. It is not a hair-care routine, it does not diagnose or treat hair loss, and it is not a substitute for a dermatologist or licensed stylist. Check the cited sources for current guidance.